Effect of a cardiac rehabilitation program based on exercise on physical capacity, cardiac function and quality of life in patients with heart failure;Efecto de un programa de rehabilitación cardiaca basado en ejercicio sobre la capacidad física, la función cardiaca y la calidad de vida, en pacientes con falla cardiaca

Revista Colombiana de Cardiologia

Volumn 18, Issue 1, 2011, Pages 25-36

  Atehortúa, Diana S ^a   Gallo, Jaime A ^b,c,d,e   Rico, Mauricio ^e   Durango, Luisa ^e  

^a Deporte y la Recreación de Itagüí   (Colombia)

^b Centro Clínico y de Investigación SICOR Soluciones Integrales en Riesgo Cardiovascular   (Colombia)

^c Grupo de investigación GRINMADE   (Colombia)

^d UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^e Clinica Cardiovascular Santa Maria   (Colombia)

Author keywords

Cardiac function; Cardiac rehabilitation; Exercise; Heart failure; Physical capacity; Quality of life

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART FUNCTION TEST; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; MALE; OXYGEN CONSUMPTION; PHYSICAL CAPACITY; QUALITY OF LIFE; QUESTIONNAIRE; WALKING;

EID: 80051570594     PISSN: 01205633     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0120-5633(11)70163-2     Document Type: Article

References (40)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348 (20): 2007-18.
2. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341 (8): 577-85.
3. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46 (6): e1-82.
4. Cubillos-Garzón LA, Casas JP, Morillo CA, Bautista LE. Congestive heart failure in Latin America: the next epidemic. Am Heart J 2004; 147 (3): 412-7.
5. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008; 117 (19): 2544-65.
6. Gallo J, Saldarriaga J, Clavijo M, Arango E, Rodríguez N, Osorio J. Actividad física y salud cardiovascular: en búsqueda de la relación dosis respuesta. Medellín: Corporación para Investigaciones Biológicas (CIB); 2010. p. 283-304
7. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003; 107 (8): 1210-25.
8. Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004; 328 (7433): 189.
9. Duscha BD, Schulze PC, Robbins JL, Forman DE. Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 2008; 13 (1): 21-37.
10. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98 (24): 2709-15.
11. Hambrecht R, Adams V, Gielen S, Linke A, Mobius-Winkler S, Yu J, et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 1999; 33 (1): 174-9.
12. Giannuzzi P, Temporelli PL, Corra U, Tavazzi L. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 2003; 108 (5): 554-9.
13. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA 2000; 283 (23): 3095-101.
14. Mezzani A, Corra U, Giannuzzi P. Central adaptations to exercise training in patients with chronic heart failure. Heart Fail Rev 2008; 13 (1): 13-20.
15. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004; 110 (13): 1780-6.
16. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001; 38 (7): 1934-41.
17. Kato M, Kinugawa T, Ogino K, Endo A, Osaki S, Igawa O, et al. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure. J Intern Med 2000; 248 (4): 309-15.
18. Arad M, Adler Y, Koren-Morag N, Natanzon S, Sela BA, Ben Dov I, et al. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels. Int J Cardiol 2008; 126 (1): 114-9.
19. Steele IC, McDowell G, Moore A, Campbell NP, Shaw C, Buchanan KD, et al. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest 1997; 27 (4): 270-6.
20. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104 (14): 1694-740.
21. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166 (1): 111-7.
22. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132 (8): 919-23.
23. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003; 16 (10): 1091-110.
24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18 (12): 1440-63.
25. Januzzi JL, Jr., Lewandrowski KB, Bashirians G, Jackson S, Freyler D, Smith K, et al. Analytical and clinical performance of the Ortho-Clinical Diagnostics VITROS amino-terminal pro-B type natriuretic peptide assay. Clin Chim Acta 2008; 387 (1-2): 48-54.
26. Lugo L, García H, Gómez C. Confiabilidad del cuestionario de calidad de vida en salud SF-36 en Medellín, Colombia. Revista Facultad de Salud Pública 2006; 24 (2): 37-50.
27. Knox SA, King MT. Validation and calibration of the SF-36 health transition question against an external criterion of clinical change in health status. Qual Life Res 2009; 18 (5): 637-45.
28. Augustovski FA, Lewin G, Elorrio EG, Rubinstein A. The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research. J Clin Epidemiol 2008; 61 (12): 1279-84.
29. Resolución 8430 de 1993 Bogotá: Ministerio de Protección Social; 1993.
30. Schuklenk U. Helsinki Declaration revisions. Issues Med Ethics 2001; 9 (1): 29.
31. Guazzi M, Dickstein K, Vicenzi M, Arena R. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail 2009; 2 (6): 549-55.
32. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007; 115 (24): 3086-94.
33. Negrao CE, Middlekauff HR. Adaptations in autonomic function during exercise training in heart failure. Heart Fail Rev 2008; 13 (1): 51-60.
34. Niebauer J. Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev 2008; 13 (1): 39-49.
35. Haykowsky MJ, Liang Y, Pechter D, Jones LW, McAlister FA, Clark AM. A metaanalysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 2007; 49 (24): 2329-36.
36. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002; 87 (3): 235-41.
37. Jeng C, Yang MH, Chen PL, Ho CH. The influence of exercise tolerance on quality of life among patients with heart failure. Qual Life Res 2004; 13 (5): 925-32.
38. Collins E, Langbein WE, Dilan-Koetje J, Bammert C, Hanson K, Reda D, et al. Effects of exercise training on aerobic capacity and quality of life in individuals with heart failure. Heart Lung 2004; 33 (3): 154-61.
39. Quittan M, Sturm B, Wiesinger GF, Pacher R, Fialka-Moser V. Quality of life in patients with chronic heart failure: a randomized controlled trial of changes induced by a regular exercise program. Scand J Rehabil Med 1999; 31 (4): 223-8.
40. Salazar A, Marqués F, Guidi D, Hanna M, Acevedo M, Yánez F, et al. Impacto del programa de rehabilitación cardiovascular fase II medido a través de la encuesta de salud SF 36. Revista Mexicana de Enfermería Cardiológica 2005; 13 (3): 77-81.